0001694665-21-000029.txt : 20210201
0001694665-21-000029.hdr.sgml : 20210201
20210201170714
ACCESSION NUMBER: 0001694665-21-000029
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210127
FILED AS OF DATE: 20210201
DATE AS OF CHANGE: 20210201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zung Jonathan B.
CENTRAL INDEX KEY: 0001837972
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38473
FILM NUMBER: 21577649
MAIL ADDRESS:
STREET 1: C/O EVELO BIOSCIENCES, INC.
STREET 2: 620 MEMORIAL DRIVE, SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evelo Biosciences, Inc.
CENTRAL INDEX KEY: 0001694665
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465594527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 620 MEMORIAL DRIVE
STREET 2: SUITE 200 WEST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617 870 8281
MAIL ADDRESS:
STREET 1: 620 MEMORIAL DRIVE
STREET 2: SUITE 200 WEST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4/A
1
wf-form4a_161221722128198.xml
FORM 4/A
X0306
4/A
2021-01-27
2021-01-29
0
0001694665
Evelo Biosciences, Inc.
EVLO
0001837972
Zung Jonathan B.
C/O EVELO BIOSCIENCES, INC.
620 MEMORIAL DRIVE
CAMBRIDGE
MA
02139
0
1
0
0
Chief Development Officer
Stock Option (Right to Buy)
16.65
2021-01-27
4
A
0
300000
0
A
2031-01-27
Common Stock
300000.0
300000
D
Restricted Stock Units
0.0
2021-01-27
4
A
0
10000
0
A
Common Stock
10000.0
10000
D
This option will vest as to 25% of the total grant on January 4, 2022 and as to the remaining 75% vesting thereafter in thirty-six (36) substantially equal monthly installments, subject to continued employment on such dates.
These Restricted Stock Units will vest in full on the third anniversary of the grant date, January 27, 2024, subject to continued employment on such date.
This Form 4/A is being filed to correct an administrative error and include all awards granted to the reporting person on January 27, 2021.
/s/ Daniel S. Char, Attorney-in-Fact for Jonathan B. Zung
2021-02-01